1. In contrast, only epithelial cells from ulcerative colitis showed an appreciable increase after calcium ionophore induction.

2. Ulcerative colitis patients Nineteen patients with ulcerative colitis undergoing colectomy were also studied.

3. Thirty patients had coexisting ulcerative colitis, including three who had previously undergone colectomy and one who discontinued treatment after three months.

4. Ulcerative colitis may present with anaemia when bowel symptoms are mild or ignored.

5. One hundred and twenty ulcerative colitis patients, 105 Crohn's disease patients and 49 controls were studied.

6. Twelve patients with ulcerative colitis had mild, 19 moderate, and 10 severe attacks.

7. Assessment of intestinal permeability in ulcerative colitis after the ingestion of various markers has yielded conflicting results.

8. Thus a considerable number of cases of both ulcerative colitis and Crohn's disease are sporadic or non-genetic.

9. The strong association between colorectal dysplasia and cancer in ulcerative colitis was described in 1967.

10. The vascular endothelium seems to produce superoxide in the inflamed mucosa, which would exacerbate tissue injury in ulcerative colitis.

11. All patients underwent colonoscopy or flexible sigmoidoscopy before study entry to confirm the diagnosis of ulcerative colitis.

12. It has been further postulated that pouchitis represents a recurrence of ulcerative colitis in reservoirs with colonic metaplasia.

13. Corticosteroid drugs are the most effective and widely used treatment for acute relapse of ulcerative colitis.

14. An alternative might be interference with bacterial adhesion by pathogenic Escherichia coli, which have abnormal adherence in ulcerative colitis.

15. Several studies have shown the efficacy of 6-mercaptopurine and azathioprine in the treatment of both ulcerative colitis and Crohn's disease.

16. All patients with sclerosing cholangitis and positive tests for anti-lactoferrin had ulcerative colitis.

17. Three studies on regional intestinal permeability in patients with ulcerative colitis have been published.

18. Bismuth enemas may offer a new therapeutic option in distal ulcerative colitis.

19. Circulating anticolon antibodies have been found in serum samples from patients with ulcerative colitis.

20. In this study we have examined both benign and malignant colorectal strictures in ulcerative colitis and have compared their features.

21. Thus it should not be assumed that older patients with ulcerative colitis have weaker sphincters than younger patients.

22. The presence of perinuclear antineutrophil cytoplasmic antibodies in unaffected family members of ulcerative colitis patients favours this view.

23. Serum concentration of interleukin-6 are also raised in active Crohn's disease but surprisingly not in ulcerative colitis.

24. Immunological abnormalities are generally accepted to be involved in the pathogenesis of ulcerative colitis.

25. Activated macrophages are prominent in the inflammatory infiltrate in both ulcerative colitis and Crohn's disease.

26. Powell-Tuck etal measured whole body protein metabolism in 19 patients with ulcerative colitis(), while they were receiving enteral or intravenous nutrition.

27. We showed that luminol enhanced chemiluminescence from colonic mucosa biopsy specimens is increased in patients with ulcerative colitis.

28. These data would argue against a pathogenic role for E coli in ulcerative colitis.

29. Further investigations are needed to determine if also this aberration is specific for ulcerative colitis.

30. In the remaining seven patients the diagnosis was made after colectomy and synchronous pouch formation despite preoperative endoscopic biopsies suggesting ulcerative colitis.

31. The other IgG subclasses were not correlated at the cellular level in either ulcerative colitis or Crohn's disease twins.

32. We have previously characterised the rectal mucosa associated microflora of patients with ulcerative colitis.

33. In conclusion, our study confirms that perinuclear antineutrophil cytoplasmic antibodies are indeed demonstrable in the large majority of ulcerative colitis patients.

34. The unsaturation index did not show differences between patients with ulcerative colitis and controls.

35. Originally only four patients were classified as having definite Crohn's disease and 15 as indeterminate colitis leaving 62 with ulcerative colitis.

36. Ulcerative colitis and Crohn's disease are chronic, remitting and relapsing mucosal disorders, collectively known as inflammatory bowel disease.

37. Of the two patients with recurrent pouchitis who have ulcerative colitis both have had pouch excision because of poor functional results.

38. Ultrastructural changes in colonic mucosa consistent with increased absorption have been described in ulcerative colitis, in both affected and unaffected areas.

39. These peptides are produced by bacteria normally found in the human bowel and in patients with ulcerative colitis.

40. We elected to include this patient in the study since the entire remaining right colon had active ulcerative colitis.

41. The functional result in patients with ulcerative colitis is extremely variable.

42. Restorative proctocolectomy is the procedure of choice for most patients who require surgical treatment for ulcerative colitis.

43. Seven patients with definite Crohn's disease, seven with indeterminate colitis and 52 with typical ulcerative colitis have a functioning pouch.

44. There was little evidence to support the presence of a primary defect in the colonic barrier in patients with ulcerative colitis.

45. Before either ulcerative colitis or Crohn's disease was diagnosed infectious and neoplastic diseases had to be ruled out.

46. Figure 2 illustrates lysozyme mRNA in a colonic biopsy specimen from a patient with longstanding ulcerative colitis.

47. Concern about nephrotoxicity has been the major factor limiting more widespread investigational use of cyclosporin in ulcerative colitis.

48. In a group of 37 ulcerative colitis patients, however, no effect of medication was found.

49. Other studies suggest that cyclosporin is of therapeutic value in ulcerative colitis, but there have been no controlled trials.

50. Therefore, of 180 patients eligible for colonic cancer surveillance in ulcerative colitis 160 were entered into the programme.

51. There has recently been a revival of interest in changes in colonic motility in ulcerative colitis.

52. Despite some similarities, it seems increasingly likely that the pathogenic mechanisms of ulcerative colitis and Crohn's disease are distinct.

53. The pathophysiological importance of the ulcerative colitis associated perinuclear antineutrophil cytoplasmic antibodies is still poorly understood.

54. Faecal occult blood studies have also uncovered previously unrecognised cases of ulcerative colitis.

55. Colitis, which is histologically similar to ulcerative colitis, has also been described in association with pellagra.

56. All patients with ulcerative colitis were in clinical remission and had normal levels of haemoglobin, C-reactive protein, and serum orosomucoid.

57. Evidence has accumulated that several autoimmune phenomena are present in ulcerative colitis patients.

58. Everyone has heard of stressed executives who suffer peptic ulcers and ulcerative colitis.

59. Platelet activating factor may be involved in the pathogenesis of ulcerative colitis as well as in experimental colitis.

60. The present study was done to extend these observations and to include sera from patients with ulcerative colitis and primary sclerosing cholangitis.

61. The pathogenesis of benign stricture formation in ulcerative colitis remains uncertain.

62. This notion was further supported by the strong correlation revealed for cellular IgG1 proportions in healthy and affected ulcerative colitis twins.

63. Crohn's colitis does not differ very much from ulcerative colitis in this regard, the reported frequency of stricture being 8%.

64. The results of restorative proctocolectomy for ulcerative colitis are variable.

65. The study included pairs of twins both concordant and discordant with regard to ulcerative colitis or Crohn's disease.

66. Biopsy specimens from control subjects and patients with ulcerative colitis were studied.

67. Systemic endotoxaemia has been demonstrated in ulcerative colitis and Crohn's disease and correlates with the extent and activity of disease.

68. Epithelial and lamina propria mononuclear cells were isolated from surgical specimens from control, Crohn's disease, and ulcerative colitis patients.

69. The diagnostic criteria for ulcerative colitis and Crohn's disease in the probands have been described.

70. Common afflictions include ulcerative colitis, diverticulosis, polyps, and tumours.

71. Ulcerative Colitis is agnogenic and refractory large intestinal disease.

72. Behcet'syndrome, Crohn disease, ulcerative colitis, Kawasaki s disease.

73. Clinical trials are under way in the U.S. and Europe testing Trichuris Suis Ova (TSO)—-a species of pig whipworm—as a treatment for peanut allergies, ulcerative colitis, Crohn's disease and MS.

74. Objective : To observe the effect of Bitnal treating chronic Ulcerative colitis by orally and vetention enema.

75. Conclusion Staphylococcus aureus enterotoxin B from sinusitis may be one of reasons resulted in ulcerative colitis.

76. These disease states can be diagnosed before concomitant with, or after the diagnosis of ulcerative colitis.

77. Objective:To study the effect of sodium ferulate on the abnormal function of platelet in patients with ulcerative colitis(UC).

78. Conclusion: The parenteral hyperalimentation therapy is a safe and effective method for severe ulcerative colitis patients, and it can improve the histology of patients.

79. Objective : To study the value of ultrasound in the diagnosis of ulcerative colitis.

80. Objective To investigate the clinical characters of the patients with ulcerative colitis (UC), as well as the efficacy and safety of azathioprine used in UC patients.

81. Method The rat model of ulcerative colitis was induced with 2 , 4,(http:///ulcerative colitis.html)6 trinitrobenzene sulfonic acid.

82. Chronic non-specific ulcerative colitis with intraepithelial neoplasia change is prone to turning to carcinoma, so it's called precancerosis of colonic carcinoma.

83. The model of Ulcerative Colitis rats was formed with method of xenogenic (rabbit) colitic mucosa immunity and stimulus on colitic region.

84. Objetive:Purslane water decoction of ulcerative colitis(UC)model in mice and its mechanism.

85. AIM: To observe the curative effect of Sanguis Draconis combined with salicylazosulfapyridine(SASP) in the treatment of non-specific ulcerative colitis(UC).

86. It may also be seen in tuberculosis, sarcoidosis, histoplasmosis, coccidioidomycosis, blastomycosis, ulcerative colitis, and with use of some medications.

87. Other:Such as nonspecific ulcerative colitis, sugar original sex diarrhea is far-gone .

88. Objective : To explore an ideal therapeutic way of drugs retention enema for childhood ulcerative colitis patients.

89. OBJECTIVE : To study the mechanism of active treatment on ulcerative colitis with Weichangning.

90. I have ulcerative colitis, and actually use the very helminths mentioned here to treat it--human whipworm or trichuris trichuria.

91. Objective The curative effect of ulcerative colitis treated with Jiechangling coloclyster coordinated with colon-instrument was observed.

92. Conclusion: Using "Clear Heat and Astring the Bowel Decoction" to treat ulcerative colitis through retention-enema had a significant therapeutic effect, and the method is easy to be generalized.

93. Chronic nonspecific ulcerative colitis is a disease with exacerbations and remissions.

94. World Health Organization has ranked ulcerative colitis, a kind of chronic inflammation whose pathogenesis we have not known, as one of the modern cureless diseases because of the high incidence.

95. Objective:To discuss the clinical efficacy of clysis with Chinese Traditional Medicine in the treatment of chronical ulcerative colitis.

96. Ulcerative colitis (UC) is a complex, polygenetic hereditary disease and its pathogenesis is not fully known yet.

97. Objective To approach the clinical therapeutic effects on light or mid-range ulcerative colitis by small dose sulfasalazine(SASP), Danshen root injection, association with Liushen pill.

98. Fusobacterium infection has already been linked with a gut condition called ulcerative colitis which is itself a risk factor for bowel cancer.

99. No specific method is developed in the treatment of ulcerative colitis, which results in a prolonged course and incurability of this disease.

100. The parenteral hyperalimentation therapy is a safe and effective method for severe ulcerative colitis patients, and it can improve the histology of patients.

101. To observe the plerosis on injury of ulcerative colitis rats with Chang-an Capsule and explore its effect mechanism.

102. To compare drug treatment for active ulcerative colitis by colon hydrotherapy instrument with conventional drugs treatment.

103. METHODS:165cases of ulcerative colitis were divided into two groups:trial group(compound glycyrrhizin)and control group(sulfasalazine). The clinical effects were compared between two groups.

104. Good combination of Chinese and Western medicine treatment of ulcerative colitis, chronic prostatitis and other diseases.

105. Ulcerative colitis is a multi systemic disease associated with many extraintestinal manifestations.

106. Ulcerative colitis ( UC ) is characterized by a chronic relapsing intestinal inflammation . The causes of UC are unknown.

107. Objective: The therapeutic effect of Tongfuning Granule on ulcerative colitis ( UC ) was researched in this experiment.

108. Inflammatory bowel disease(IBD) includes ulcerative colitis(UC) and Crohn's disease(CD). The pathophysiology mechanisms of the disease remains elusive.

109. Objective: To study the clinical effects of parenteral hyperalimentation in severe ulcerative colitis patients.

110. Objective To study the role of Staphylococcus aureus enterotoxin B from sinusitis in pathogenesis of ulcerative colitis.

111. Conclusions Drug treatment through sigmoidoscope is a effective,() safe a nd convenient therapeutic way for ulcerative colitis.

112. Ulcerative colitis - related mortality accounted for 17 % of all deaths.

113. Indigestion, Stomach-ache, Diarrhea, Vomiting, Nausea, Constipation, Hiccup, Prolapse of Stomach, Ulcerative Colitis.

114. Inflammatory bowel disease such as ulcerative colitis and Crohn's disease may occur here.

115. Methods Real time helical scanning and tree-D reconstruction on the work station were accessed on ulcerative colitis cases proved by colonoscopy.

116. Objective: To observe the clinical effect of "Clear Heat and Astring the Bowel Decoction" to treat ulcerative colitis which belong to damp-heat through retention-enema.

117. Over time, there is a risk for adenocarcinoma with ulcerative colitis.

118. Objective To study the effects of sodium ferulate(SF) on the abnormal function of platelet in patients with ulcerative colitis(UC).

119. This gross appearance is characteristic for ulcerative colitis. The most intense inflammation begins at the lower right in the sigmoid colon and extends upward and around to the ascending colon.

120. Objective : To study the anti - inflammatory effects of Jianpilichang tablets on chronic nonspecific ulcerative colitis.

121. Disease Activity, ANCA, and IL23R Genotype Status Determine Early Response to Infliximab in Patients With Ulcerative Colitis.

122. Ulcerative colitis and granulomatous colitis affect many children and young adults.

123. There are hormones, sulfanilamide groups and immunosuppressant for treatment in ulcerative colitis.

124. There are now many of us using trichuris trichuria to treat Ulcerative Colitis.

125. Pseudopolyps are seen here in a case of severe ulcerative colitis. The remaining mucosa has been ulcerated away and is hyperemic .

126. Mucosanguineous stool is a warning of malignant tumors of the colon and ulcerative colitis.

127. Objective To explore the efficacy of compound lactobacillus acidophilus combined with salazosulfapyridine coloclysis for ulcerative colitis.

128. Having ulcerative colitis , which is a chronic condition, puts aa higher risk of developing bowel cancer.